You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CVKD Award Disclosure
Cole Jeffrey Scott · SEC Form 4 · Filed Oct 13, 2026
Award
Calculated transaction value
$0
Cole Jeffrey Scott Chief Operating Officer
CVKD
Transaction date
Oct 9, 2026
Public filing date
Oct 13, 2026
Filing lag
Filed 4 days later
CVKD daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option on Common Stock
- Quantity / price
- 150,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001213900-26-109129
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Cadrenal Therapeutics, Inc. CVKD Current | Award | Oct 9, 2026 | $0 |